A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials. - Fertitta L; Bergqvist C; Sarin KY; Plotkin SR; Moertel C; Petersen AK; Cannon A; Berman Y; Pichard DC; Röhl C; Lessing A; Brizion B; et al. (The British journal of dermatology, 2024)